As observed for AML cells and GM-CSF-matured MDMs, the treatment of lung macrophages with infliximab decreased the amount of O2− produced in response to stimulation with PMA or PMA plus IFNγ (Fig. 4g,h). This evidence concerns the gene IFNG and acute myeloid leukemia.